{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:23:34Z","timestamp":1793125414943,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007592","name":"Al-Balqa' Applied University","doi-asserted-by":"publisher","award":["2021\/2020\/497"],"award-info":[{"award-number":["2021\/2020\/497"]}],"id":[{"id":"10.13039\/100007592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020328","name":"University of Petra","doi-asserted-by":"publisher","award":["09\/04\/2020"],"award-info":[{"award-number":["09\/04\/2020"]}],"id":[{"id":"10.13039\/100020328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Apitherapy is an emerging field in cancer research, particularly in developing communities. The potency of Melittin (MEL), a major constituent in bee venom is accounted for the cytotoxic capacity against cancer cells. It is postulated that the genotype of bees and the time of venom collection influences its specific activity against certain types of cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Hereby, Jordanian crude bee venom (JCBV) was collected during different seasons of the year, specifically spring, summer and autumn and investigated for in vitro antitumour effects. Venom collected during springtime comprised the highest quantity of MEL in comparison to venom collected some other time. Springtime-collected JCBV extract and MEL were tested on an immortal myelogenous leukaemia cell line, namely K562 leukemic cells. Treated cells were examined for cell modality via flow cytometry analysis and cell death mediating gene expressions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Springtime-collected JCBV extract and MEL showed an IC<jats:sub>50<\/jats:sub> of 3.7\u2009\u00b1\u20090.37\u00a0\u03bcg\/ml and 1.84\u2009\u00b1\u20090.75\u00a0\u03bcg\/ml, respectively. In comparison to JCBV and positive control, MEL-treated cells exhibited late apoptotic death with a moderate cellular arrest at G0\/G1 and an increase of cell number at G2\/M phase. Expression of NF-\u03baB\/MAPK14 axis was inhibited in MEL and JCBV-treated cells, as well as expression of c-MYC and CDK4. Moreover, marked upregulation in ABL1, JUN and TNF was observed. In conclusion, springtime-collected JCBV showed the highest content of MEL while both JCBV and pure MEL showed apoptotic, necrotic, and cell cycle arrest efficiency against K562 leukemic cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Integration of bee venom in chemotherapy needs more investigation and should be carefully translated into clinical use. During such translation, the correlation of bee genotype, collection time and concentration of MEL in CBV should be profiled.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-03897-x","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T11:11:26Z","timestamp":1682421086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line"],"prefix":"10.1186","volume":"23","author":[{"given":"Maher","family":"Obeidat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab F.","family":"Al-khraisat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da\u2019san M. M.","family":"Jaradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan Y.","family":"Ghanim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qasem M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa Abu","family":"Arqoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola M.","family":"Al-Sanabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawfiq","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal A.","family":"Qinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"148","key":"3897_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.toxicon.2018.04.012","volume":"15","author":"S Zhang","year":"2018","unstructured":"Zhang S, Liu Y, Ye Y, Wang XR, Lin LT, Xiao LY, et al. Bee venom therapy: Potential mechanisms and therapeutic applications. Toxicon. 2018;15(148):64\u201373.","journal-title":"Toxicon"},{"key":"3897_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.fct.2014.03.022","volume":"68","author":"YJ Jeong","year":"2014","unstructured":"Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK, et al. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K\/Akt\/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol. 2014;68:218\u201325.","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"3897_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/molecules24050929","volume":"24","author":"HN Lim","year":"2019","unstructured":"Lim HN, Baek SB, Jung HJ. Bee venom and its peptide component Melittin suppress growth and migration of melanoma cells via inhibition of PI3K\/Akt\/mTOR and MAPK pathways. Molecules. 2019;24(5):929.","journal-title":"Molecules"},{"issue":"8","key":"3897_CR4","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3390\/toxins6082210","volume":"6","author":"KE Choi","year":"2014","unstructured":"Choi KE, Hwang CJ, Gu SM, Park MH, Kim JH, Park JH, et al. Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells. Toxins (Basel). 2014;6(8):2210\u201328.","journal-title":"Toxins (Basel)"},{"issue":"402","key":"3897_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","volume":"28","author":"I Rady","year":"2017","unstructured":"Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;28(402):16.","journal-title":"Cancer Lett"},{"issue":"1","key":"3897_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3897_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bbrc.2006.02.090","volume":"343","author":"SC Park","year":"2006","unstructured":"Park SC, Kim JY, Shin SO, Jeong CY, Kim MH, Shin SY, et al. Investigation of toroidal pore and oligomerization by Melittin using transmission electron microscopy. Biochem Biophys Res Commun. 2006;343(1):222\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3897_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.toxicon.2008.06.007","volume":"52","author":"WC Tu","year":"2008","unstructured":"Tu WC, Wu CC, Hsieh HL, Chen CY, Hsu SL. Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells. Toxicon. 2008;52(2):318\u201329.","journal-title":"Toxicon"},{"issue":"3","key":"3897_CR9","first-page":"324","volume":"27","author":"M Sisakht","year":"2017","unstructured":"Sisakht M, Mashkani B, Bazi A, Ostadi H, Zare M, Avval FZ, et al. Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells. Rev Bras. 2017;27(3):324\u20138.","journal-title":"Rev Bras"},{"issue":"1","key":"3897_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41698-020-00129-0","volume":"4","author":"C Duffy","year":"2020","unstructured":"Duffy C, Sorolla A, Wang E, Golden E, Woodward E, Davern K, et al. Honeybee venom and Melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. npj Precision Oncol. 2020;4(1):24.","journal-title":"npj Precision Oncol"},{"issue":"1","key":"3897_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.taap.2011.10.009","volume":"258","author":"M Jo","year":"2012","unstructured":"Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, et al. Anti-cancer effect of bee venom toxin and Melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2\/STAT3 pathway. Toxicol Appl Pharmacol. 2012;258(1):72\u201381.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"3897_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.stem.2008.05.018","volume":"3","author":"A Raouf","year":"2008","unstructured":"Raouf A, Zhao Y, To K, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell. 2008;3(1):109\u201318.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"3897_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bioinformatics\/btp053","volume":"25","author":"DJ McCarthy","year":"2009","unstructured":"McCarthy DJ, Smyth GK. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics. 2009;25(6):765\u201371.","journal-title":"Bioinformatics"},{"issue":"10","key":"3897_CR14","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1073\/pnas.0500369102","volume":"102","author":"MJ Peart","year":"2005","unstructured":"Peart MJ, Smyth GK, van Laar RK, et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci U S A. 2005;102(10):3697\u2013702.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3897_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/biom10020247","volume":"10","author":"M Ceremuga","year":"2020","unstructured":"Ceremuga M, Stela M, Janik E, Gorniak L, Synowiec E, Sliwinski T, et al. Melittin-A Natural Peptide from Bee Venom Which Induces Apoptosis in Human Leukaemia Cells. Biomolecules. 2020;10(2):247.","journal-title":"Biomolecules"},{"key":"3897_CR16","doi-asserted-by":"crossref","unstructured":"Ghanim BY, Qinna NA. Nrf2\/ARE axis signalling in hepatocyte cellular death. Molecular Biology Reports. 2022;(49):4039\u201353.","DOI":"10.1007\/s11033-022-07125-6"},{"issue":"3","key":"3897_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejphar.2010.10.023","volume":"650","author":"DJ Keith","year":"2011","unstructured":"Keith DJ, Eshleman AJ, Janowsky A. Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane spanning proteins. Eur J Pharmacol. 2011;650(3):501\u201310.","journal-title":"Eur J Pharmacol"},{"key":"3897_CR18","doi-asserted-by":"crossref","unstructured":"Haas E, Stanley DW. Phospholipase A2. xPharm: The Comprehensive Pharmacology Reference. 2007 Jan 1;1\u20132.","DOI":"10.1016\/B978-008055232-3.60538-0"},{"issue":"12","key":"3897_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):1\u201321.","journal-title":"Genome Biol"},{"key":"3897_CR20","doi-asserted-by":"crossref","unstructured":"Carr\u00e0 G, Torti D, Crivellaro S, Panuzzo C, Taulli R, Cilloni D, et al. The BCR-ABL\/NF-\u03baB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias. Oncotarget. 2016;7(40). Available from: www.impactjournals.com\/oncotarget\/","DOI":"10.18632\/oncotarget.11507"},{"key":"3897_CR21","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.bcp.2020.113947","volume":"177","author":"X Qin","year":"2020","unstructured":"Qin X, Hu L, Shi S nan, Chen X, Zhuang C, Zhang W, et al. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ame-liorates acute kidney injury by targeting RIPK1 and RIPK3 kinases. Biochem Pharmacol. 2020;177:113947.","journal-title":"Biochem Pharmacol"},{"key":"3897_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-015-0407-0","volume":"14","author":"N Sharma","year":"2015","unstructured":"Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P, et al. BCR\/ABL1 and BCR are under thetranscriptional control of the MYC oncogene. Mol Cancer. 2015;14:132.","journal-title":"Mol Cancer"},{"issue":"65","key":"3897_CR23","doi-asserted-by":"publisher","first-page":"108880","DOI":"10.18632\/oncotarget.22353","volume":"8","author":"L Ma","year":"2017","unstructured":"Ma L, Xu Z, Wang J, Zhu Z, Lin G, Jiang L, et al. Matrine inhibits BCR\/ABL mediated ERK\/MAPK pathway in human leukemia cells. Oncotarget. 2017;8(65):108880\u20139.","journal-title":"Oncotarget"},{"key":"3897_CR24","doi-asserted-by":"publisher","first-page":"524308","DOI":"10.1155\/2012\/524308","volume":"2012","author":"F Tzifi","year":"2012","unstructured":"Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S, Scorilas A. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol. 2012;2012:524308.","journal-title":"Adv Hematol"},{"key":"3897_CR25","first-page":"215158","volume":"2010","author":"M Diederich","year":"2010","unstructured":"Diederich M, Sobolewski C, Cerella C, Dicato M, Ghibelli L. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol. 2010;2010:215158.","journal-title":"Int J Cell Biol"},{"key":"3897_CR26","doi-asserted-by":"crossref","unstructured":"Shortt J, Johnstone RW. Oncogenes in cell survival and cell death. Cold Spring Harbor Perspectives in Biology. 2012;4(12)1-10.","DOI":"10.1101\/cshperspect.a009829"},{"issue":"11","key":"3897_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers10110448","volume":"10","author":"CJ Poole","year":"2018","unstructured":"Poole CJ, Zheng W, Lee H, Young D, Lodh A, Chadli A, et al. Targeting the MYC oncogene in burkitt lymphoma through HSP90 inhibition. Cancers (Basel). 2018;10(11):1\u201313.","journal-title":"Cancers (Basel)"},{"issue":"15","key":"3897_CR28","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1182\/blood-2010-07-299644","volume":"117","author":"K Kollmann","year":"2011","unstructured":"Kollmann K, Heller G, Ott RG, Scheicher R, Zebedin-Brandl E, Schneckenleithner C, et al. c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5\u2019 region of CDK6. Blood. 2011;117(15):4065\u201375.","journal-title":"Blood"},{"issue":"6","key":"3897_CR29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cellsig.2009.12.008","volume":"22","author":"E Shaulian","year":"2010","unstructured":"Shaulian E. AP-1 - The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell Signal. 2010;22(6):894\u20139.","journal-title":"Cell Signal"},{"issue":"148","key":"3897_CR30","first-page":"14","volume":"1","author":"X Gao","year":"2020","unstructured":"Gao X, Leone GW, Wang H. Cyclin D-CDK4\/6 functions in cancer. Adv Cancer Res [Internet]. 2020;1(148):14.","journal-title":"Adv Cancer Res [Internet]"},{"issue":"4","key":"3897_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00218839.2020.1801073","volume":"60","author":"DC de Graaf","year":"2021","unstructured":"de Graaf DC, Brochetto Braga MR, de Abreu RMM, Blank S, Bridts CH, De Clerck LS, et al. Standard methods for Apis mellifera venom research. J Apic Res. 2021;60(4):1\u201331.","journal-title":"J Apic Res"},{"issue":"3","key":"3897_CR32","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nprot.2006.179","volume":"1","author":"V Vichai","year":"2006","unstructured":"Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112\u20136.","journal-title":"Nat Protoc"},{"issue":"21","key":"3897_CR33","doi-asserted-by":"publisher","first-page":"e1984","DOI":"10.21769\/BioProtoc.1984","volume":"6","author":"E Orellana","year":"2016","unstructured":"Orellana E, Kasinski A. Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation. Bio-Protocol. 2016;6(21):e1984.","journal-title":"Bio-Protocol"},{"key":"3897_CR34","doi-asserted-by":"crossref","unstructured":"Ghanim B, Ahmad M, Abdallah Q, Qatouseh L, Qinna N. Modulation of NRF2\/ARE pathway- and cell death-related genes during drug-induced liver injury. Human & Experimental Toxicology. 2021;40(12):2223-36.","DOI":"10.1177\/09603271211027947"},{"issue":"1","key":"3897_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12865-020-0334-8","volume":"21","author":"JG Roy","year":"2020","unstructured":"Roy JG, McElhaney JE, Verschoor CP. Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus. BMC Immunol. 2020;21(1):4.","journal-title":"BMC Immunol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-03897-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T11:11:37Z","timestamp":1682421097000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-03897-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3897"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-03897-x","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Venom collection protocol was ethically revised and approved during research application by the scientific committee of the Deanship of Scientific Research, Al-Balqa\u2019 Applied University.; Approval Number (2021\/2020\/497).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}